• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证 MyDiagnostick 工具在多族裔亚洲人群中识别房颤的能力。

Validation of MyDiagnostick tool to identify atrial fibrillation in a multi-ethnic Asian population.

机构信息

Cardiology Department, Changi General Hospital, Singapore.

Cardiology Department, Changi General Hospital; Orchard Heart Specialist Clinic, Mount Elizabeth Hospital, Singapore.

出版信息

Singapore Med J. 2023 Jul;64(7):430-433. doi: 10.11622/smedj.2022028.

DOI:10.11622/smedj.2022028
PMID:35196846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10395807/
Abstract

INTRODUCTION

MyDiagnostick is an atrial fibrillation (AF) screening tool that has been validated in the Caucasian population in the primary care setting.

METHODS

In our study, we compared MyDiagnostick with manual pulse check for AF screening in the community setting.

RESULTS

In our cohort of 671 candidates from a multi-ethnic Asian population, AF prevalence was found to be 1.78%. Of 12 candidates, 6 (50.0%) had a previous history of AF and another 6 (50.0%) were newly diagnosed with AF. Candidates found to have AF during the screening were older (72.0 ± 11.7 years vs. 56.0 ± 13.0 years, P < 0.0001) and had a higher CHADSVASC risk score (2.9 ± 1.5 vs. 1.5 ± 1.1, P = 0.0001). MyDiagnostick had a sensitivity of 100.0% and a specificity of 96.2%. In comparison, manual pulse check had a sensitivity of 83.3% and a specificity of 98.9%.

CONCLUSION

MyDiagnostick is a simple AF screening device that can be reliably used by non-specialist professionals in the community setting. Its sensitivity and specificity are comparable and validated across various studies performed in different population cohorts.

摘要

简介

MyDiagnostick 是一种心房颤动(AF)筛查工具,已在初级保健环境中的白种人群中得到验证。

方法

在我们的研究中,我们将 MyDiagnostick 与手动脉搏检查进行了比较,以进行社区环境中的 AF 筛查。

结果

在我们来自多民族亚洲人群的 671 名候选者队列中,AF 的患病率为 1.78%。在 12 名候选者中,有 6 名(50.0%)有 AF 的既往病史,另有 6 名(50.0%)新诊断为 AF。在筛查期间发现患有 AF 的候选者年龄较大(72.0±11.7 岁 vs. 56.0±13.0 岁,P<0.0001),且 CHADSVASC 风险评分较高(2.9±1.5 vs. 1.5±1.1,P=0.0001)。MyDiagnostick 的敏感性为 100.0%,特异性为 96.2%。相比之下,手动脉搏检查的敏感性为 83.3%,特异性为 98.9%。

结论

MyDiagnostick 是一种简单的 AF 筛查设备,可由社区环境中的非专业人员可靠使用。其敏感性和特异性在不同人群队列中进行的各种研究中是可比且经过验证的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d9/10395807/5d34d8164141/SMJ-64-430-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d9/10395807/d2bc1fd71a40/SMJ-64-430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d9/10395807/5d34d8164141/SMJ-64-430-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d9/10395807/d2bc1fd71a40/SMJ-64-430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d9/10395807/5d34d8164141/SMJ-64-430-g002.jpg

相似文献

1
Validation of MyDiagnostick tool to identify atrial fibrillation in a multi-ethnic Asian population.验证 MyDiagnostick 工具在多族裔亚洲人群中识别房颤的能力。
Singapore Med J. 2023 Jul;64(7):430-433. doi: 10.11622/smedj.2022028.
2
Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation.一种用于筛查心房颤动的新型诊断设备的验证及临床应用
Europace. 2014 Sep;16(9):1291-5. doi: 10.1093/europace/euu057. Epub 2014 May 13.
3
The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care.MyDiagnostick在基层医疗中检测心房颤动的诊断准确性。
BMC Fam Pract. 2014 Jun 9;15:113. doi: 10.1186/1471-2296-15-113.
4
Performance of handheld electrocardiogram devices to detect atrial fibrillation in a cardiology and geriatric ward setting.手持式心电图设备在心脏病学和老年病科病房环境中检测心房颤动的性能。
Europace. 2017 Jan;19(1):29-39. doi: 10.1093/europace/euw025. Epub 2016 Feb 17.
5
Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.荷兰基层医疗中使用手持式单导联心电图设备筛查心房颤动的成本效益分析。
Europace. 2018 Jan 1;20(1):12-18. doi: 10.1093/europace/euw285.
6
Screening for paroxysmal atrial fibrillation in primary care using Holter monitoring and intermittent, ambulatory single-lead electrocardiography.在初级保健中使用动态心电图监测和间歇性、动态单导联心电图筛查阵发性心房颤动。
Int J Cardiol. 2021 Dec 15;345:41-46. doi: 10.1016/j.ijcard.2021.10.021. Epub 2021 Oct 21.
7
Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study.用于心房颤动筛查的血液生物标志物和设备:来自 AFRICAT(加泰罗尼亚心房颤动研究)研究的经验教训。
PLoS One. 2022 Aug 23;17(8):e0273571. doi: 10.1371/journal.pone.0273571. eCollection 2022.
8
Detection of atrial fibrillation in primary care with radial pulse palpation, electronic blood pressure measurement and handheld single-lead electrocardiography: a diagnostic accuracy study.在基层医疗中使用桡动脉触诊、电子血压测量和手持式单导联心电图检测心房颤动:一项诊断准确性研究。
BMJ Open. 2022 Jun 29;12(6):e059172. doi: 10.1136/bmjopen-2021-059172.
9
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.一项针对65岁及以上人群检测心房颤动的系统筛查(针对性筛查和全人群筛查)与常规做法的随机对照试验及成本效益研究。SAFE研究。
Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74. doi: 10.3310/hta9400.
10
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.心房颤动的筛查策略:系统评价与成本效益分析
Health Technol Assess. 2017 May;21(29):1-236. doi: 10.3310/hta21290.

引用本文的文献

1
Electrocardiogram Devices for Home Use: Technological and Clinical Scoping Review.家用心电图设备:技术与临床范围综述
JMIR Cardio. 2023 Jul 7;7:e44003. doi: 10.2196/44003.
2
A meta-analysis of extended ECG monitoring in detection of atrial fibrillation in patients with cryptogenic stroke.一项关于延长心电图监测在隐源性卒中患者中检测心房颤动的荟萃分析。
Open Heart. 2022 Sep;9(2). doi: 10.1136/openhrt-2022-002081.

本文引用的文献

1
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.大规模评估智能手表以识别心房颤动。
N Engl J Med. 2019 Nov 14;381(20):1909-1917. doi: 10.1056/NEJMoa1901183.
2
Effectiveness of a nongovernmental organization-led large-scale community atrial fibrillation screening program using the smartphone electrocardiogram: An observational cohort study.非政府组织主导的使用智能手机心电图进行大规模社区心房颤动筛查计划的效果:一项观察性队列研究。
Heart Rhythm. 2018 Sep;15(9):1306-1311. doi: 10.1016/j.hrthm.2018.06.006. Epub 2018 Jun 8.
3
Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch.
使用市售智能手表进行心房颤动的被动检测。
JAMA Cardiol. 2018 May 1;3(5):409-416. doi: 10.1001/jamacardio.2018.0136.
4
Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting.在初级保健机构中,AliveCor心脏监测仪与Microlife WatchBP Office AFIB用于心房颤动筛查的直接比较
Circulation. 2017 Jan 3;135(1):110-112. doi: 10.1161/CIRCULATIONAHA.116.024439.
5
Wireless Smartphone ECG Enables Large-Scale Screening in Diverse Populations.无线智能手机心电图可实现对不同人群的大规模筛查。
J Cardiovasc Electrophysiol. 2015 May;26(5):520-6. doi: 10.1111/jce.12634. Epub 2015 Mar 19.
6
Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation.对大量当代新发非瓣膜性心房颤动患者队列的患病率、发病率、管理及结局进行的前瞻性全国性研究。
J Am Heart Assoc. 2015 Jan 21;4(1):e001486. doi: 10.1161/JAHA.114.001486.
7
The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care.MyDiagnostick在基层医疗中检测心房颤动的诊断准确性。
BMC Fam Pract. 2014 Jun 9;15:113. doi: 10.1186/1471-2296-15-113.
8
Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation.一种用于筛查心房颤动的新型诊断设备的验证及临床应用
Europace. 2014 Sep;16(9):1291-5. doi: 10.1093/europace/euu057. Epub 2014 May 13.
9
Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study.心房颤动、卒中风险和华法林治疗再探讨:一项基于人群的研究。
Stroke. 2013 Nov;44(11):3103-8. doi: 10.1161/STROKEAHA.113.002329. Epub 2013 Aug 27.
10
Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0).在家中监测血压时筛查无症状性心房颤动:常规脉搏与不规则脉搏监测预防卒中的试验(TRIPPS 2.0)。
Am J Cardiol. 2013 Jun 1;111(11):1598-601. doi: 10.1016/j.amjcard.2013.01.331. Epub 2013 Mar 15.